The FDA draft guidance "Considerations for Complying with 21 CFR 211.110" raises points to consider regarding drug products ...
By Amy Guest, SAERI PhD and University of Aberdeen student - During the second week of September (9-12th), I attended ICYMARE ...
For dedicated hosts, trivia is a craft and commitment. Where they’re successful, regulars return each week, loyal to their ...
The Southern California Biomedical Council (SoCalBio) today announced that two of Southern California’s most accomplished ...
Years before people develop rheumatoid arthritis, their blood teems with activated immune cells that could serve as ...
The rollout of the H-1B visa change has sewn confusion – and some fear another ‘body blow’ for US science.
The FDA declined to approve a higher dose of nusinersen – the medication in Biogen’s spinal muscular atrophy treatment ...
Seven-year study reveals early warning signs that could help doctors catch rheumatoid arthritis before symptoms begin ...
If you're thinking about adding more protein to your diet, experts say you can expect to see several changes in your body, ...
In response, through the Protecting Nova Scotians Act, the Houston government is introducing changes to the Crown Lands Act ...
A new Fred Hutch study surprisingly finds that many drugs initially written off as ineffective on cultured cancer cell lines ...
PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit speaks with PanCAN’s Chief Business Officer, Sudheer Doss, PhD, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback